VANCOUVER, BRITISH COLUMBIA -- (MARKET WIRE) -- May 15, 2007 -- Chemokine Therapeutics Corp. (the “Company”) (TSX: CTI)(OTCBB: CHKT), a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases, today announced the financial and operating results of the first quarter ended March 31, 2007.
